Showing results (81-90 of 438) with videos related to
Sort By:
Pageof 44
European Journal of Gastroenterology & Hepatology|November 1, 1996
Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four casesP Mathurin, J F Cadranel, D Bouraya, et al.The Journal of Urology|May 20, 1999
CD44 is an independent prognostic factor in conventional renal cell carcinomasV Paradis, S Ferlicot, E Ghannam, et al.Human Pathology|October 22, 1998
Clonal analysis of renal sporadic angiomyolipomasV Paradis, I Laurendeau, A Vieillefond, et al.Alimentary Pharmacology & Therapeutics|January 19, 2007
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemiaV Ratziu, P Giral, M Munteanu, et al.Alimentary Pharmacology & Therapeutics|August 6, 1998
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?P Mathurin, O Rixe, N Carbonell, et al.Alimentary Pharmacology & Therapeutics|August 24, 2016
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological referenceM Munteanu, D Tiniakos, Q Anstee, et al.Virchows Archiv : an International Journal of Pathology|June 2, 2000
Expression of vascular endothelial growth factor in renal cell carcinomasV Paradis, N B Lagha, L Zeimoura, et al.Gastroenterologie Clinique Et Biologique|July 31, 2009
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trialsT Poynard, J Massard, M Rudler, et al.Acta Gastro-Enterologica Belgica|January 29, 1999
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologieT Poynard, J Moussalli, V Ratziu, et al.Presse Medicale (Paris, France : 1983)|February 27, 1988
[Evaluation of the methodological quality of randomized therapeutic trials]T PoynardPageof 44